Through the new collaborating centre, WHO will expand access to structured, competency-based regulatory training and support the development of a stronger workforce capable of regulating medicines and vaccines.
The guidance recommends that Ervebo® should currently be used against Bundibugyo virus (BDBV) only within a research protocol.
The agreement builds on Peking University’s longstanding involvement in global health research and public health capacity development.
The Autoridade Nacional Reguladora de Medicamentos de Moçambique (ANARME) has achieved Maturity Level 3 (ML3) for regulating medicines and imported vaccines under WHO’s global classification of national regulatory authorities.
The assessment, conducted from July 27–31, 2026, evaluated the country’s regulatory strengths and gaps and will support updates to EFDA’s Institutional Development Plan.
Leishmaniasis is endemic in 80 countries, with an estimated 50,000 to 90,000 new cases reported annually, although WHO estimates that only 25% to 45% of infections are officially documented.
The guidance updates dosing recommendations for several widely used paediatric antiretroviral medicines, including dolutegravir and the combination of abacavir and lamivudine.
The campaigns vaccinated 936,618 children during the first round, 997,941 during the second and 1,025,806 during the third.
The designation highlights Abu Dhabi’s expanding role in global health security, particularly in strengthening systems that detect, track, and respond to infectious disease threats.
The donation includes 108 electric obstetric theatre beds, along with specialised equipment for women’s cancer screening, diagnosis, and treatment.